Moderate hypofractionated radiotherapy is more effective and safe for localized prostate cancer patients: a meta-analysis

about

Moderate hypofractionated radiotherapy is more effective and safe for localized prostate cancer patients: a meta-analysis

Item

http://www.wikidata.org/entity/Q36214859

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Moderate hypofractionated radi ...... ncer patients: a meta-analysis

@ast

Moderate hypofractionated radi ...... ncer patients: a meta-analysis

@en

type

Item

label

Moderate hypofractionated radi ...... ncer patients: a meta-analysis

@ast

Moderate hypofractionated radi ...... ncer patients: a meta-analysis

@en

prefLabel

Moderate hypofractionated radi ...... ncer patients: a meta-analysis

@ast

Moderate hypofractionated radi ...... ncer patients: a meta-analysis

@en

P1476

Moderate hypofractionated radi ...... ncer patients: a meta-analysis

@en

P2093

Hong-Fen Wu

http://www.w3.org/2001/XMLSchema#string

Ling Cao

http://www.w3.org/2001/XMLSchema#string

Ping Wang

http://www.w3.org/2001/XMLSchema#string

Shi-Xin Liu

http://www.w3.org/2001/XMLSchema#string

Yong-Jing Yang

http://www.w3.org/2001/XMLSchema#string

Zhu-Chun Yang

http://www.w3.org/2001/XMLSchema#string

P2860

The Efficacy of Erlotinib Versus Conventional Chemotherapy for Advanced Nonsmall-Cell Lung Cancer: A PRISMA-Compliant Systematic Review With Meta-Regression and Meta-Analysis

Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials.

Effectiveness and safety of bevacizumab for unresectable non-small-cell lung cancer: a meta-analysis.

Increasing use of dose-escalated external beam radiation therapy for men with nonmetastatic prostate cancer

Is alpha/beta for prostate tumors really low?

Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial

Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer.

Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

Hypofractionated external-beam radiation therapy (HEBRT) versus conventional external-beam radiation (CEBRT) in patients with localized prostate cancer: a systematic review and meta-analysis

Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee

P304

2647-2658

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.18632/ONCOTARGET.13735

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Zhi-Wen Li

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27926521

http://www.w3.org/2001/XMLSchema#string

P932

5356830

http://www.w3.org/2001/XMLSchema#string